Associated Papers
Genetic and epigenetic insights into non-obstructive azoospermia: mechanisms, biomarkers, and clinical perspectives.
Wang X et al.
Reproductive Biology and Endocrinology : Rb&e, 2025
Summarizing the human genes and their variants causative of non-obstructive azoospermia uncovered using whole genome/exome sequencing.
Ibrahim R et al.
Reproductive Biology, 2025
A Novel Compound Heterozygous Mutation in TDRD9 Causes Oligozoospermia.
Wang W et al.
Reproductive Sciences (thousand Oaks, Calif.), 2024
Whole exome sequencing analysis of 167 men with primary infertility.
Zhou H et al.
Bmc Medical Genomics, 2024
Burden of Mendelian disorders in a large Middle Eastern biobank.
Aamer W et al.
Genome Medicine, 2024
38584274 (PubMed )
Supplement: 13073_2024_1307_MOESM1_ESM.xlsx › Table_S3
Genetic variants underlying spermatogenic arrests in men with non-obstructive azoospermia.
Ozturk S
Cell Cycle (georgetown, Tex.), 2023
Genetic control of meiosis surveillance mechanisms in mammals.
Huang Y et al.
Frontiers in Cell and Developmental Biology, 2023
36910159 (PubMed )
Supplement: DataSheet2.PDF
Whole-exome sequencing improves the diagnosis and care of men with non-obstructive azoospermia.
Kherraf ZE et al.
American Journal of Human Genetics, 2022
Molecular genetics of infertility: loss-of-function mutations in humans and corresponding knockout/mutated mice.
Jiao SY et al.
Human Reproduction Update, 2021
A systematic review on the genetics of male infertility in the era of next-generation sequencing.
Robay A et al.
Arab Journal of Urology, 2018
Mutation in TDRD9 causes non-obstructive azoospermia in infertile men.
Arafat M et al.
Journal of Medical Genetics, 2017
Select a paper to view details